Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Polycystic Ovary Syndrome 10Insulin Resistance 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Prostatic Neoplasms 4Carcinoma, Non-Small-Cell Lung 3Pancreatic Neoplasms 2Leukoplakia, Oral 2Leukemia, Myeloid, Chronic-Phase 2Diabetes Mellitus, Type 2 2Carotid Intimal Medial Thickness 1 2Breast Neoplasms 2Thyroid Cancers That Contain the PAX8-PPARgamma Fusion Gene 1Sleep Apnea, Obstructive 1Skin Neoplasms 1Recurrence 1Prostatic Neoplasms, Castration-Resistant 1Pharmacokinetics of MDV3100 1Neoplasm Metastasis 1Multiple Myeloma 1Metabolic Syndrome 1Meningioma 1Memory Disorders 1Lung Neoplasms 1Liposarcoma, Myxoid 1Liposarcoma 1Leukemia, Myeloid, Acute 1Inflammation 1Hyperinsulinism 1Head and Neck Neoplasms 1Glucose Intolerance 1

Interventions

lithium sulfate 1Sugars 1Pioglitazone 1Methods 1Lithium 1Donepezil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Memory Disorders × Pioglitazone × Clear all
NCT01151670 2018-08-01

Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain Tumors

Wake Forest University Health Sciences

Phase 1 Completed
18 enrolled
CNS

Astrocytoma, Brain Neoplasms, Glioblastoma, Memory Disorders, Meningioma, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡